Timetable: Accelerated assessment request for initial marketing authorisations - ATMP

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - March 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 March 2024, 10:00 (CET) to 19 March 2024, 12:00 (CET)

European Shortages Monitoring Platform

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Betmiga, mirabegron, Date of authorisation: 20/12/2012, Revision: 14, Status: Authorised

Draft template for assessment report for the development of European herbal monographs and European Union list entries - Revision 6

Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1

Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Kinzalkomb, telmisartan,hydrochlorothiazide, Date of authorisation: 19/04/2002, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR): Dabigatran Etexilate Leon Farma, dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 1, Status: Authorised